{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:31:42Z","timestamp":1786995102072,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","nucmedbio.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.nucmedbio.2016.09.002","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T04:27:36Z","timestamp":1474000056000},"page":"105-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Inhibition of viability of microorganisms in [18F]-labeled radiopharmaceuticals"],"prefix":"10.1016","volume":"44","author":[{"given":"G.","family":"J\u00f6rg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fosselmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Leis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Oberdorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ch.","family":"Fehsenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2016.09.002_bb0005","author":"Eudralex"},{"key":"10.1016\/j.nucmedbio.2016.09.002_bb0010","author":"FDA"},{"issue":"5","key":"10.1016\/j.nucmedbio.2016.09.002_bb0015","article-title":"Small molecule radiopharmaceuticals \u2013 a review of current approaches","volume":"3","author":"Chaturvedi","year":"2016","journal-title":"Front Med"},{"issue":"4","key":"10.1016\/j.nucmedbio.2016.09.002_bb0020","first-page":"365","article-title":"PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence","volume":"4","author":"Lopci","year":"2014","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2016.09.002_bb0025","series-title":"IAEA-TECDOC-1228","article-title":"Therapeutic applications of radiopharmaceuticals","author":"International Atomic Energy Agency (IAEA)","year":"2001"},{"key":"10.1016\/j.nucmedbio.2016.09.002_bb0030","series-title":"Brookhaven National Laboratory report BNL-68381","article-title":"Production considerations for the \u201cclassical\u201d PET nuclides","author":"Finn","year":"2001"},{"issue":"6","key":"10.1016\/j.nucmedbio.2016.09.002_bb0035","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1046\/j.1365-2672.1999.00948.x","article-title":"A review: taking the sterile out of sterility","volume":"87","author":"Allison","year":"1999","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.nucmedbio.2016.09.002_bb0040","series-title":"Chapters Radiopharmaceuticals and Sterility tests","article-title":"Ph. Int., International Pharmacopoeia Issue 5","year":"2015"},{"issue":"1","key":"10.1016\/j.nucmedbio.2016.09.002_bb0045","first-page":"43","article-title":"Sterilization methods and the comparison of e-beam sterilization with gamma radiation sterilization","volume":"34","author":"Silindir","year":"2009","journal-title":"FABAD J Pharm Sci"},{"issue":"3","key":"10.1016\/j.nucmedbio.2016.09.002_bb0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1128\/AEM.4.3.153-155.1956","article-title":"Incidence and characteristics of beta radiation survivors (Escherichia coli)","volume":"4","author":"Koh","year":"1956","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.nucmedbio.2016.09.002_bb0055","series-title":"Issue 8.8: Chapter 5.1.1","author":"Ph. Eur., European Pharmacopoeia","year":"2016"},{"key":"10.1016\/j.nucmedbio.2016.09.002_bb0060","first-page":"3","article-title":"The limits of sterility assurance","volume":"3","author":"Von Woedtke","year":"2008","journal-title":"GMS Krankenhhyg Interdiszip"},{"issue":"1","key":"10.1016\/j.nucmedbio.2016.09.002_bb0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0969-806X(98)00206-0","article-title":"Substantiation of 25kGy as a sterilization dose: a rational approach to establishing verification dose","volume":"54","author":"Kowalski","year":"1999","journal-title":"Radiat Phys Chem"},{"issue":"7","key":"10.1016\/j.nucmedbio.2016.09.002_bb0070","doi-asserted-by":"crossref","first-page":"a012765","DOI":"10.1101\/cshperspect.a012765","article-title":"Biology of extreme radiation resistance: the way of Deinococcus radiodurans","volume":"5","author":"Krisko","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"10.1016\/j.nucmedbio.2016.09.002_bb0075","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1574-6968.2008.01076.x","article-title":"Fungi and ionizing radiation from radionuclides","volume":"281","author":"Dighton","year":"2008","journal-title":"FEMS Microbiol Lett"},{"issue":"6","key":"10.1016\/j.nucmedbio.2016.09.002_bb0080","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.mib.2008.09.013","article-title":"Ionizing radiation: how fungi cope, adapt, and exploit with the help of melanin","volume":"11","author":"Dadachova","year":"2008","journal-title":"Curr Opin Microbiol"},{"issue":"7","key":"10.1016\/j.nucmedbio.2016.09.002_bb0085","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1128\/AEM.70.7.4230-4241.2004","article-title":"Geomicrobiology of high-level nuclear waste-contaminated vadose sediments at the Hanford site, Washington state","volume":"70","author":"Fredrickson","year":"2004","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.nucmedbio.2016.09.002_bb0090","first-page":"281","article-title":"Chernobyl's radioactive impact on microbial biota","volume":"1181","author":"Yablokov","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nucmedbio.2016.09.002_bb0095","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1099\/jmm.0.46488-0","article-title":"Effect of gamma irradiation on viability and DNA of Staphylococcus epidermidis and Escherichia coli","volume":"55","author":"Trampuz","year":"2006","journal-title":"J Med Microbiol"},{"issue":"2","key":"10.1016\/j.nucmedbio.2016.09.002_bb0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3923\/rjet.2009.94.100","article-title":"Effects of gamma irradiation on fungal growth and associated pathogens","volume":"3","author":"Shathele","year":"2009","journal-title":"Res J Environ Toxicol"},{"issue":"4","key":"10.1016\/j.nucmedbio.2016.09.002_bb0105","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1128\/AEM.15.4.785-789.1967","article-title":"Effects of continuous and interrupted radiation on microorganisms","volume":"15","author":"Borick","year":"1967","journal-title":"Appl Microbiol"},{"issue":"6","key":"10.1016\/j.nucmedbio.2016.09.002_bb0110","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.4315\/0362-028X-69.6.1430","article-title":"Effect of gamma or beta radiation on Salmonella DT 104 in ground pork","volume":"69","author":"Rajkowski","year":"2006","journal-title":"J Food Prot"},{"issue":"9","key":"10.1016\/j.nucmedbio.2016.09.002_bb0115","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.4014\/jmb.1202.02039","article-title":"Development of a qualitative dose indicator for gamma radiation using lyophilized Deinococcus","volume":"22","author":"Lim","year":"2012","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.nucmedbio.2016.09.002_bb0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00006231-198605000-00002","article-title":"The sterility testing of dispensed radiopharmaceuticals","volume":"7","author":"Brown","year":"1986","journal-title":"Nucl Med Commun"},{"issue":"4","key":"10.1016\/j.nucmedbio.2016.09.002_bb0125","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/ajhp\/40.4.634","article-title":"Effect of technetium Tc 99m pertechnetate on bacterial survival in solution","volume":"40","author":"Stathis","year":"1983","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"10.1016\/j.nucmedbio.2016.09.002_bb0130","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.2349\/biij.2.4.e57","article-title":"Review of 18F-FDG synthesis and quality control","volume":"2","author":"Yu","year":"2006","journal-title":"Biomed Imaging Interv J"},{"issue":"3","key":"10.1016\/j.nucmedbio.2016.09.002_bb0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12149-010-0343-4","article-title":"An efficient and aseptic preparation of \u201csodium fluoride (18F) injection\u201d in a GMP compliant facility","volume":"24","author":"Kao","year":"2010","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.nucmedbio.2016.09.002_bb0140","series-title":"Gamma radiation","first-page":"171","article-title":"Sterilization by gamma irradiation","author":"Aquino","year":"2012"},{"issue":"6","key":"10.1016\/j.nucmedbio.2016.09.002_bb0145","doi-asserted-by":"crossref","first-page":"062503","DOI":"10.1118\/1.4876296","article-title":"On the dose calculation at the cellular level and its implications for the RBE of 99mTc and 123I","volume":"41","author":"Freudenberg","year":"2014","journal-title":"Med Phys"},{"issue":"45","key":"10.1016\/j.nucmedbio.2016.09.002_bb0150","doi-asserted-by":"crossref","first-page":"8012","DOI":"10.1016\/j.vaccine.2011.08.055","article-title":"Evaluation of growth based rapid microbiological methods for sterility testing of vaccines and other biological products","volume":"29","author":"Parveen","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.nucmedbio.2016.09.002_bb0155","first-page":"52","article-title":"Rapid and traditional methods in the contract microbiological laboratory","volume":"7","author":"Murdoch","year":"2015","journal-title":"Int Pharm Ind"},{"key":"10.1016\/j.nucmedbio.2016.09.002_bb0160","article-title":"A fresh look at USP <1223> Validation of alternative microbiological methods and how the revised chapter compares with PDA TR33 and the proposed revision to Ph. Eur. 5.1.6","author":"Miller","year":"2015","journal-title":"Am Pharm Rev"},{"key":"10.1016\/j.nucmedbio.2016.09.002_bb0165","series-title":"Rapid sterility testing","author":"Moldenhauer","year":"2011"},{"issue":"8","key":"10.1016\/j.nucmedbio.2016.09.002_bb0170","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2967\/jnumed.114.138057","article-title":"Prevalence of adverse events to radiopharmaceuticals from 2007 to 2011","volume":"55","author":"Silberstein","year":"2014","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.nucmedbio.2016.09.002_bb0175","first-page":"185","article-title":"Prevalence of adverse reactions in nuclear medicine","volume":"37","author":"Silberstein","year":"1996","journal-title":"J Nucl Med"},{"issue":"684","key":"10.1016\/j.nucmedbio.2016.09.002_bb0180","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1259\/0007-1285-57-684-1091","article-title":"Adverse reactions to radiopharmaceuticals. United Kingdom 1977-1983","volume":"57","author":"Keeling","year":"1984","journal-title":"Br J Radiol"},{"issue":"1","key":"10.1016\/j.nucmedbio.2016.09.002_bb0185","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/MAJ.0b013e318216ee86","article-title":"Pitfalls with radiopharmaceuticals","volume":"342","author":"Santos-Oliveira","year":"2011","journal-title":"Am J Med Sci"},{"issue":"8","key":"10.1016\/j.nucmedbio.2016.09.002_bb0190","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s00259-012-2120-1","article-title":"Further considerations on adverse reactions to radiopharmaceuticals","volume":"39","author":"Salvatori","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805116301767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805116301767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T22:17:01Z","timestamp":1601072221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805116301767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":38,"alternative-id":["S0969805116301767"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2016.09.002","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of viability of microorganisms in [18F]-labeled radiopharmaceuticals","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2016.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}